8-K Announcements
6Material company update
Mar 17, 2026·SEC
Material company update
Feb 26, 2026·SEC
Material company update
Jan 8, 2026·SEC
Personalis, Inc.(PSNL)Earnings, Financials & Key Ratios
PSNL•NASDAQ
$6.07
$542M mkt cap·Price updated May 6, 2026
AboutPersonalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.Show more
- Revenue$0-100.0%
- EBITDA-$88M-53.6%
- Net Income-$81M
- EPS (Diluted)-0.91+33.6%
- ROE-35.02%+28.4%
- ROIC-40.69%-9.7%
- Debt/Equity0.12-44.0%
PSNL Key Insights
Personalis, Inc. (PSNL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak momentum: RS Rating 16 (bottom 16%)
- ✗Shares diluted 50.6% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
PSNL Price & Volume
Personalis, Inc. (PSNL) stock price & volume — 10-year historical chart
Loading chart...
PSNL Growth Metrics
Personalis, Inc. (PSNL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-38.19%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM0.02%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM33.58%
Return on Capital
10 Years-36.03%
5 Years-35.19%
3 Years-38.67%
Last Year-33%
PSNL Recent Earnings
Personalis, Inc. (PSNL) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 9/12 qtrs (75%)
Q1 2026Latest
Feb 26, 2026EPS
$0.26
Est $0.31
+16.1%
Revenue
$17M
Est $17M
+1.7%
Q4 2025
Nov 4, 2025EPS
$0.24
Est $0.28
+14.3%
Revenue
$14M
Est $17M
-14.9%
Q3 2025
Aug 5, 2025EPS
$0.23
Est $0.25
+8.0%
Revenue
$17M
Est $20M
-14.5%
Q2 2025
May 6, 2025EPS
$0.18
Est $0.23
+21.7%
Revenue
$21M
Est $17M
+18.3%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 26, 2026 | $0.26vs $0.31+16.1% | $17Mvs $17M+1.7% |
| Q4 2025 | Nov 4, 2025 | $0.24vs $0.28+14.3% | $14Mvs $17M-14.9% |
| Q3 2025 | Aug 5, 2025 | $0.23vs $0.25+8.0% | $17Mvs $20M-14.5% |
| Q2 2025 | May 6, 2025 | $0.18vs $0.23+21.7% | $21Mvs $17M+18.3% |
Based on last 12 quarters of dataView full earnings history →
PSNL Peer Comparison
Personalis, Inc. (PSNL) competitors in Molecular and Genetic Diagnostics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NTRA | 29.58B | 215.09 | -140.58 | 56.75% | -14.61% | -24.69% | 0.16 | |
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 GH | 11.53B | 92.25 | -27.79 | 32.88% | -44.18% | |||
 TWST | 3.71B | 59.53 | -45.79 | 20.32% | -19.85% | -17.46% | 0.29 | |
 ILMN | 21.66B | 142.58 | 26.16 | -0.78% | 19.43% | 32.84% | 0.94 | |
 PACB | 516.17M | 1.71 | -1.60 | -23.19% | -325.8% | -13.95% | 1.33 | |
 CDNA | 1.08B | 20.94 | -52.35 | 13.79% | -1.98% | -2.61% | 0.06 | |
 VCYT | 3.29B | 41.19 | 50.23 | 16.01% | 16.25% | 6.86% | 0.03 |
Compare PSNL vs Peers
Personalis, Inc. (PSNL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PSNL Income Statement
Personalis, Inc. (PSNL) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 9.39M | 37.77M | 65.21M | 78.65M | 85.49M | 65.05M | 73.48M | 84.61M | 0 |
| Revenue Growth % | - | 302.15% | 72.62% | 20.61% | 8.7% | -23.92% | 12.97% | 15.15% | -100% |
| Cost of Goods Sold | 11.74M | 25.97M | 43.13M | 58.53M | 53.84M | 51.7M | 55.27M | 57.79M | 53.87M |
| COGS % of Revenue | 124.94% | 68.75% | 66.14% | 74.43% | 62.97% | 79.48% | 75.22% | 68.3% | - |
| Gross Profit | -2.34M▲ 0% | 11.8M▲ 603.8% | 22.08M▲ 87.0% | 20.11M▼ 8.9% | 31.66M▲ 57.4% | 13.35M▼ 57.8% | 18.21M▲ 36.4% | 26.82M▲ 47.3% | -53.87M▼ 300.8% |
| Gross Margin % | -24.94% | 31.25% | 33.86% | 25.57% | 37.03% | 20.52% | 24.78% | 31.7% | - |
| Gross Profit Growth % | - | 603.84% | 87.04% | -8.9% | 57.39% | -57.83% | 36.39% | 47.33% | -300.82% |
| Operating Expenses | 19.82M | 25.57M | 44.5M | 62.26M | 97.01M | 128.88M | 128.14M | 95.09M | 103.83M |
| OpEx % of Revenue | 211.01% | 67.71% | 68.24% | 79.16% | 113.47% | 198.14% | 174.39% | 112.38% | - |
| Selling, General & Admin | 9.9M | 11.27M | 22.08M | 33.69M | 47.7M | 63.97M | 49.73M | 46.19M | 53.57M |
| SG&A % of Revenue | 105.41% | 29.84% | 33.86% | 42.84% | 55.79% | 98.34% | 67.67% | 54.59% | - |
| Research & Development | 9.92M | 14.3M | 22.42M | 28.57M | 49.31M | 64.91M | 64.78M | 48.91M | 50.26M |
| R&D % of Revenue | 105.6% | 37.87% | 34.38% | 36.32% | 57.68% | 99.79% | 88.15% | 57.8% | - |
| Other Operating Expenses | 0 | -33K | 0 | 0 | 0 | 0 | 13.64M | 0 | 0 |
| Operating Income | -22.16M▲ 0% | -13.77M▲ 37.9% | -22.42M▼ 62.8% | -42.15M▼ 88.0% | -65.35M▼ 55.1% | -115.53M▼ 76.8% | -109.94M▲ 4.8% | -68.27M▲ 37.9% | -88.06M▼ 29.0% |
| Operating Margin % | -235.95% | -36.45% | -34.38% | -53.59% | -76.44% | -177.61% | -149.61% | -80.68% | - |
| Operating Income Growth % | - | 37.87% | -62.8% | -88% | -55.06% | -76.78% | 4.84% | 37.9% | -28.99% |
| EBITDA | -20.95M | -10.7M | -17.67M | -36.39M | -59.34M | -107.1M | -98.64M | -57.33M | -88.06M |
| EBITDA Margin % | -223.01% | -28.34% | -27.1% | -46.27% | -69.41% | -164.65% | -134.24% | -67.75% | - |
| EBITDA Growth % | - | 48.9% | -65.08% | -105.93% | -63.07% | -80.49% | 7.9% | 41.88% | -53.61% |
| D&A (Non-Cash Add-back) | 1.22M | 3.07M | 4.75M | 5.76M | 6.01M | 8.43M | 11.3M | 10.94M | 0 |
| EBIT | -22.29M | -17.98M | -23.94M | -41.22M | -65.03M | -113.07M | -108.1M | -81.24M | 0 |
| Net Interest Income | -1.2M | -1.6M | 487K | 947K | 183K | 2.19M | 5.79M | 5.49M | 0 |
| Interest Income | 100K | 293K | 1.62M | 949K | 367K | 2.4M | 5.9M | 5.51M | 7.16M |
| Interest Expense | 1.3M | 1.89M | 1.13M | 2K | 184K | 201K | 110K | 24K | -205K |
| Other Income/Expense | -1.43M | -6.11M | -2.66M | 923K | 141K | 2.26M | 1.72M | -13M | 6.81M |
| Pretax Income | -23.59M▲ 0% | -19.88M▲ 15.7% | -25.07M▼ 26.1% | -41.22M▼ 64.4% | -65.21M▼ 58.2% | -113.28M▼ 73.7% | -108.21M▲ 4.5% | -81.27M▲ 24.9% | -81.25M▲ 0.0% |
| Pretax Margin % | -251.18% | -52.63% | -38.45% | -52.41% | -76.28% | -174.14% | -147.27% | -96.04% | - |
| Income Tax | 5K | 7K | 9K | 57K | 14K | 40K | 83K | 18K | 21K |
| Effective Tax Rate % | -0.02% | -0.04% | -0.04% | -0.14% | -0.02% | -0.04% | -0.08% | -0.02% | -0.03% |
| Net Income | -23.6M▲ 0% | -19.89M▲ 15.7% | -25.08M▼ 26.1% | -41.28M▼ 64.6% | -65.23M▼ 58.0% | -113.31M▼ 73.7% | -108.3M▲ 4.4% | -81.28M▲ 24.9% | -81.27M▲ 0.0% |
| Net Margin % | -251.23% | -52.64% | -38.47% | -52.49% | -76.29% | -174.2% | -147.38% | -96.06% | - |
| Net Income Growth % | - | 15.73% | -26.14% | -64.57% | -58.01% | -73.73% | 4.43% | 24.94% | 0.02% |
| Net Income (Continuing) | -23.6M | -19.89M | -25.08M | -41.28M | -65.23M | -113.31M | -108.3M | -81.28M | -81.27M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.08▲ 0% | -0.91▲ 15.7% | -1.39▼ 52.7% | -1.20▲ 13.7% | -1.49▼ 24.2% | -2.48▼ 66.4% | -2.25▲ 9.3% | -1.37▲ 39.1% | -0.91▲ 33.6% |
| EPS Growth % | - | 15.74% | -52.75% | 13.67% | -24.17% | -66.44% | 9.27% | 39.11% | 33.58% |
| EPS (Basic) | -1.08 | -0.91 | -1.39 | -1.20 | -1.49 | -2.48 | -2.25 | -1.37 | -0.91 |
| Diluted Shares Outstanding | 21.75M | 21.75M | 18.01M | 34.37M | 43.89M | 45.7M | 48.18M | 59.25M | 89.24M |
| Basic Shares Outstanding | 21.75M | 21.75M | 18.01M | 34.37M | 43.89M | 45.7M | 48.18M | 59.25M | 89.24M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
PSNL Balance Sheet
Personalis, Inc. (PSNL) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 26.73M | 29.56M | 139.58M | 220.72M | 318.23M | 199.7M | 146.74M | 203.01M | 267.95M |
| Cash & Short-Term Investments | 22.62M | 19.74M | 128.29M | 203.29M | 287.06M | 167.66M | 114.18M | 185.01M | 239.95M |
| Cash Only | 22.62M | 19.74M | 55.05M | 68.53M | 105.58M | 89.13M | 56.98M | 91.42M | 124.25M |
| Short-Term Investments | 0 | 0 | 73.24M | 134.76M | 181.48M | 78.53M | 57.2M | 93.59M | 115.71M |
| Accounts Receivable | 1.94M | 4.46M | 3.3M | 6.35M | 18.47M | 16.64M | 17.73M | 8.14M | 16.2M |
| Days Sales Outstanding | 75.27 | 43.07 | 18.47 | 29.47 | 78.85 | 93.38 | 88.07 | 35.11 | - |
| Inventory | 822K | 2.13M | 1.42M | 2.67M | 4.08M | 6.38M | 5.66M | 3.98M | 6.14M |
| Days Inventory Outstanding | 25.56 | 29.99 | 12.05 | 16.68 | 27.67 | 45.07 | 37.38 | 25.11 | 41.63 |
| Other Current Assets | 542K | 1.3M | 3.18M | 2.96M | 1.53M | 9.02M | 9.17M | 5.89M | 5.65M |
| Total Non-Current Assets | 6.84M | 12.11M | 17.71M | 24.12M | 78.3M | 93M | 78.36M | 67.25M | 66.21M |
| Property, Plant & Equipment | 6.34M | 11.45M | 15.95M | 22.11M | 73.47M | 88.42M | 75.22M | 64.73M | 59.93M |
| Fixed Asset Turnover | 1.48x | 3.30x | 4.09x | 3.56x | 1.16x | 0.74x | 0.98x | 1.31x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 495K | 659K | 1.76M | 2.02M | 4.83M | 4.59M | 3.14M | 2.53M | 6.28M |
| Total Assets | 33.56M▲ 0% | 41.67M▲ 24.2% | 157.29M▲ 277.5% | 244.84M▲ 55.7% | 396.53M▲ 62.0% | 292.7M▼ 26.2% | 225.1M▼ 23.1% | 270.27M▲ 20.1% | 334.16M▲ 23.6% |
| Asset Turnover | 0.28x | 0.91x | 0.41x | 0.32x | 0.22x | 0.22x | 0.33x | 0.31x | - |
| Asset Growth % | - | 24.15% | 277.47% | 55.66% | 61.95% | -26.18% | -23.1% | 20.07% | 23.64% |
| Total Current Liabilities | 48.99M | 57.85M | 49.96M | 40.64M | 31.31M | 33.13M | 47.23M | 31.13M | 39.63M |
| Accounts Payable | 4.04M | 6.57M | 7.34M | 8.3M | 9.22M | 12.85M | 14.92M | 6.4M | 12.99M |
| Days Payables Outstanding | 125.49 | 92.27 | 62.1 | 51.76 | 62.52 | 90.75 | 98.53 | 40.4 | 88.01 |
| Short-Term Debt | 17.51M | 5M | 0 | 0 | 1.81M | 2.22M | 1.65M | 1.67M | 0 |
| Deferred Revenue (Current) | 24.71M | 42.9M | 35.98M | 21.03M | 4.36M | 1.29M | 3.29M | 3.1M | 0 |
| Other Current Liabilities | 718K | 43.18M | 4.39M | 8.45M | 11.19M | 9.55M | 19.62M | 10.86M | 39.63M |
| Current Ratio | 0.55x | 0.51x | 2.79x | 5.43x | 10.16x | 6.03x | 3.11x | 6.52x | 6.76x |
| Quick Ratio | 0.53x | 0.47x | 2.77x | 5.37x | 10.03x | 5.83x | 2.99x | 6.39x | 6.61x |
| Cash Conversion Cycle | -24.66 | -19.21 | -31.57 | -5.62 | 44 | 47.7 | 26.93 | 19.82 | - |
| Total Non-Current Liabilities | 77.18M | 90.21M | 639K | 9.26M | 54.91M | 41.43M | 48.42M | 36.19M | 33.35M |
| Long-Term Debt | 292K | 683K | 0 | 0 | 0 | 0 | 0 | 0 | 31.87M |
| Capital Lease Obligations | 0 | 0 | 639K | 8.54M | 52.8M | 41.04M | 38.32M | 34.88M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 76.89M | 89.53M | 0 | 720K | 2.12M | 389K | 10.1M | 1.3M | 1.48M |
| Total Liabilities | 126.17M | 148.06M | 50.6M | 49.9M | 86.23M | 74.56M | 95.66M | 67.31M | 72.98M |
| Total Debt | 17.51M | 5M | 2M | 10.99M | 58.33M | 48.65M | 47.73M | 44.25M | 31.87M |
| Net Debt | -5.11M | -14.75M | -53.05M | -57.54M | -47.25M | -40.48M | -9.26M | -47.17M | -92.38M |
| Debt / Equity | - | - | 0.02x | 0.06x | 0.19x | 0.22x | 0.37x | 0.22x | 0.12x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -17.01x | -7.27x | -19.79x | -21073.00x | -355.18x | -574.78x | -999.42x | -2844.46x | - |
| Total Equity | -92.6M▲ 0% | -106.39M▼ 14.9% | 106.69M▲ 200.3% | 194.94M▲ 82.7% | 310.3M▲ 59.2% | 218.14M▼ 29.7% | 129.44M▼ 40.7% | 202.96M▲ 56.8% | 261.19M▲ 28.7% |
| Equity Growth % | - | -14.89% | 200.28% | 82.72% | 59.17% | -29.7% | -40.66% | 56.79% | 28.69% |
| Book Value per Share | -4.26 | -4.89 | 5.92 | 5.67 | 7.07 | 4.77 | 2.69 | 3.43 | 2.93 |
| Total Shareholders' Equity | -92.6M | -106.39M | 106.69M | 194.94M | 310.3M | 218.14M | 129.44M | 202.96M | 261.19M |
| Common Stock | 1K | 1K | 3K | 4K | 4K | 5K | 5K | 9K | 10K |
| Retained Earnings | -95.62M | -115.5M | -140.59M | -181.87M | -247.09M | -360.41M | -468.71M | -549.99M | -631.26M |
| Treasury Stock | -3.02M | -9.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -10K | -15K | -6K | 22K | -166K | -912K | -222K | -23K | 104K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PSNL Cash Flow Statement
Personalis, Inc. (PSNL) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 290K | 5.57M | -18.07M | -42.65M | -70.83M | -70.23M | -56.26M | -45.15M | -74.95M |
| Operating CF Margin % | 3.09% | 14.75% | -27.71% | -54.23% | -82.85% | -107.97% | -76.56% | -53.36% | - |
| Operating CF Growth % | - | 1821.38% | -424.28% | -136.06% | -66.06% | 0.84% | 19.9% | 19.74% | -65.99% |
| Net Income | -23.6M | -19.89M | -25.08M | -41.28M | -65.23M | -113.31M | -108.3M | -81.28M | -81.27M |
| Depreciation & Amortization | 1.22M | 3.07M | 4.75M | 5.76M | 6.01M | 8.43M | 11.3M | 10.94M | 10.05M |
| Stock-Based Compensation | 753K | 1.32M | 4.86M | 8.24M | 14.38M | 19.43M | 14.05M | 10.69M | 9.43M |
| Deferred Taxes | 226K | 4.47M | 3.11M | 391K | 2.03M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 934K | 1.18M | 1.56M | 1.47M | 3.12M | 4.61M | 13.21M | 17.1M | -13.15M |
| Working Capital Changes | 20.76M | 15.42M | -7.26M | -17.23M | -31.14M | 10.61M | 13.48M | -2.59M | 0 |
| Change in Receivables | -1.2M | -2.52M | 1.07M | -3.05M | -12.12M | 1.82M | -1.09M | 9.59M | -8.06M |
| Change in Inventory | -539K | -2.07M | -1.17M | -1.08M | 29K | -2.98M | -1.93M | 4.42M | -204K |
| Change in Payables | 2.63M | 2.16M | 1.4M | 751K | -1.46M | 3.09M | 5.18M | -8.92M | 4.55M |
| Cash from Investing | -5.16M | -7.85M | -81.58M | -65.14M | -60.07M | 52.54M | 13.1M | -35.07M | -22.57M |
| Capital Expenditures | -5.16M | -7.85M | -8.38M | -3.25M | -11.08M | -49.9M | -10.91M | -1.6M | -4.5M |
| CapEx % of Revenue | 54.91% | 20.79% | 12.85% | 4.13% | 12.96% | 76.71% | 14.85% | 1.89% | - |
| Acquisitions | 0 | 0 | 73.2M | 65.14M | 48.99M | 0 | -24.01M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -73.2M | -65.14M | -48.99M | 0 | 24.01M | 242K | 0 |
| Cash from Financing | 16.4M | -591K | 134.95M | 121.27M | 169.7M | 1.37M | 11.03M | 114.67M | 130.34M |
| Debt Issued (Net) | 16.4M | -645K | -5M | 0 | 3.31M | -1.1M | 174K | -1.13M | 0 |
| Equity Issued (Net) | 0 | 0 | 1000K | 1000K | 1000K | 0 | 1000K | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 2K | 54K | -4.08M | 3.77M | 4.13M | 2.46M | 7.34M | 17.98M | 130.34M |
| Net Change in Cash | 11.54M▲ 0% | -2.87M▼ 124.9% | 35.3M▲ 1328.8% | 13.48M▼ 61.8% | 38.85M▲ 188.2% | -16.46M▼ 142.4% | -32.14M▼ 95.3% | 34.43M▲ 207.1% | 32.83M▼ 4.6% |
| Free Cash Flow | -4.87M▲ 0% | -2.28M▲ 53.2% | -26.45M▼ 1060.1% | -45.9M▼ 73.5% | -81.91M▼ 78.5% | -120.13M▼ 46.7% | -67.17M▲ 44.1% | -46.75M▲ 30.4% | -79.45M▼ 69.9% |
| FCF Margin % | -51.83% | -6.04% | -40.56% | -58.36% | -95.81% | -184.68% | -91.41% | -55.25% | - |
| FCF Growth % | - | 53.16% | -1060.13% | -73.52% | -78.46% | -46.66% | 44.09% | 30.39% | -69.94% |
| FCF per Share | -0.22 | -0.10 | -1.47 | -1.34 | -1.87 | -2.63 | -1.39 | -0.79 | -0.89 |
| FCF Conversion (FCF/Net Income) | -0.01x | -0.28x | 0.72x | 1.03x | 1.09x | 0.62x | 0.52x | 0.56x | 0.92x |
| Interest Paid | 321K | 698K | 1.26M | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | -5K | -7K | 6K | 35K | 39K | 47K | 64K | 38K | 0 |
PSNL Key Ratios
Personalis, Inc. (PSNL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -16611.92% | -27.37% | -25.82% | -42.89% | -62.31% | -48.91% | -35.02% |
| Return on Invested Capital (ROIC) | - | - | -31.34% | -33.09% | -24.48% | -39.32% | -55.37% | -37.11% | -40.69% |
| Gross Margin | -24.94% | 31.25% | 33.86% | 25.57% | 37.03% | 20.52% | 24.78% | 31.7% | - |
| Net Margin | -251.23% | -52.64% | -38.47% | -52.49% | -76.29% | -174.2% | -147.38% | -96.06% | - |
| Debt / Equity | - | - | 0.02x | 0.06x | 0.19x | 0.22x | 0.37x | 0.22x | 0.12x |
| Interest Coverage | -17.01x | -7.27x | -19.79x | -21073.00x | -355.18x | -574.78x | -999.42x | -2844.46x | - |
| FCF Conversion | -0.01x | -0.28x | 0.72x | 1.03x | 1.09x | 0.62x | 0.52x | 0.56x | 0.92x |
| Revenue Growth | - | 302.15% | 72.62% | 20.61% | 8.7% | -23.92% | 12.97% | 15.15% | -100% |
PSNL SEC Filings & Documents
Personalis, Inc. (PSNL) SEC filings — annual & quarterly reports (10-K, 10-Q)
PSNL Frequently Asked Questions
Personalis, Inc. (PSNL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Personalis, Inc. (PSNL) reported $52.3M in revenue for fiscal year 2025. This represents a 457% increase from $9.4M in 2017.
Personalis, Inc. (PSNL) saw revenue decline by 100.0% over the past year.
Personalis, Inc. (PSNL) reported a net loss of $81.3M for fiscal year 2025.
Dividend & Returns
Personalis, Inc. (PSNL) has a return on equity (ROE) of -35.0%. Negative ROE indicates the company is unprofitable.
Personalis, Inc. (PSNL) had negative free cash flow of $79.5M in fiscal year 2025, likely due to heavy capital investments.
Explore More PSNL
Personalis, Inc. (PSNL) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates